Royal Liver’s members have approved the proposed takeover by Royal London.
Royal Liver will now apply to the FSA for approval to effect a transfer of the firm’s assets and liabilities to Royal London.
The FSA, which has been close to the discussions between the two companies, is not expected to intervene. Other parties will also have an opportunities to raise concerns about the transaction with the regulator.
If regulatory approval is received, the transfer will complete on July 1.